— Know what they know.
Not Investment Advice

LIANY OTC

LianMedical
1W: -2.9% 1M: +45.6% 3M: -47.3% YTD: -38.7% 1Y: +7.9% 3Y: +698.5%
$0.06
+0.01 (+14.22%)
 
Weekly Expected Move ±30.6%
$0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 66 · $6.4M mcap · 108M float · 0.020% daily turnover · Short 78% of daily vol

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 1Hold: 1Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
92
Earnings Quality
52
Growth
—
Value
83
Momentum
—
Safety
50
Cash Flow
—

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.48
Grey Zone
Piotroski F-Score
6/9
✓ ✓ ✓ ✗ ✓ ✓ ✓ ✗ ✗
Beneish M-Score
—
—
Ohlson O-Score
-25.15
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A-
Score: 69.2/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 0.82x
Accruals: 11.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. LIANY scores 2.48, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. LIANY scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. LIANY's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. LIANY receives an estimated rating of A- (score: 69.2/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). LIANY's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
1.29x
PEG
0.00x
P/S
0.00x
P/B
0.31x
P/FCF
0.01x
P/OCF
0.01x
EV/EBITDA
-1.80x
EV/Revenue
—
EV/EBIT
-1.79x
EV/FCF
-2.18x
Earnings Yield
13360.33%
FCF Yield
11000.48%
Shareholder Yield
0.00%
Graham Number
$18.74
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 1.3x earnings, LIANY trades at a deep value multiple. An earnings yield of 13360.3% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $18.74 per share, suggesting a potential 32075% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.999
NI / EBT
×
Interest Burden
0.999
EBT / EBIT
×
EBIT Margin
—
EBIT / Rev
×
Asset Turnover
0.000
Rev / Assets
×
Equity Multiplier
1.115
Assets / Equity
=
ROE
74.7%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. LIANY's ROE of 74.7% is driven by A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$24.69
Price/Value
0.00x
Margin of Safety
99.91%
Premium
-99.91%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with LIANY's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. At an intrinsic value of $24.69, LIANY appears undervalued with a 100% margin of safety. The adjusted fair P/E of 8.5x compares to the current market P/E of 1.3x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1201 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.06
Median 1Y
$0.03
5th Pctile
$0.00
95th Pctile
$0.20
Ann. Volatility
122.5%
25th–75th percentile 5th–95th percentile Median path Historical

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
163
+52.3% YoY
Revenue / Employee
—
Profit / Employee
$-675,822
NI: $-110,159,000
SGA / Employee
$395,798
Avg labor cost proxy
R&D / Employee
$366,160
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Current
ROE -6.0% -14.8% -31.2% -41.5% -36.0% -37.3% -33.4% -37.0% 74.7% 74.67%
ROA -5.0% -11.8% -24.6% -32.2% -29.6% -29.8% -26.4% -28.6% 67.0% 66.96%
ROIC 70.0% 1.2% 2.3% 2.7% 2.6% 2.3% 2.0% 1.8% -6.1% -6.12%
ROCE -5.4% -13.0% -26.7% -35.0% -37.8% -38.7% -33.1% -36.6% 54.1% 54.09%
Gross Margin — — — — — — — — — —
Operating Margin — — — — — — — — — —
Net Margin — — — — — — — — — —
EBITDA Margin — — — — — — — — — —
FCF Margin — — — — — — — — — —
OCF Margin — — — — — — — — — —
ROE 3Y Avg snapshot only 1.87%
ROA 3Y Avg snapshot only 3.79%
ROIC Economic snapshot only -17.07%
Cash ROA snapshot only 41.90%
Cash ROIC snapshot only 15.91%
CROIC snapshot only 15.88%
Valuation
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Current
P/E Ratio -0.15 -0.04 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.01 1.289
P/S Ratio — — — — — — — — — 0.000
P/B Ratio 0.01 0.01 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.309
P/FCF -0.10 -0.04 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.01 0.009
P/OCF — — — — — — — — 0.01 0.009
EV/EBITDA 17.22 7.26 3.47 2.61 2.61 2.59 2.90 2.78 -1.80 -1.802
EV/Revenue — — — — — — — — — —
EV/EBIT 17.03 7.18 3.45 2.65 2.66 2.63 3.09 2.86 -1.79 -1.787
EV/FCF 12.08 8.14 3.83 3.04 2.94 2.68 3.11 2.96 -2.18 -2.176
Earnings Yield -6.6% -25.3% -80.5% -107.4% -127.9% -104.4% -72.2% -113.3% 133.6% 133.60%
FCF Yield -9.7% -23.0% -74.3% -95.6% -117.0% -102.9% -71.2% -108.3% 110.0% 110.00%
PEG Ratio snapshot only 0.002
Price/Tangible Book snapshot only 0.004
EV/OCF snapshot only -2.173
Shareholder Yield snapshot only 0.00%
Graham Number snapshot only $18.74
Leverage & Solvency
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Current
Current Ratio 26.48 15.35 15.80 14.72 13.24 11.42 12.62 10.06 17.03 17.027
Quick Ratio 26.48 15.35 15.80 14.72 13.24 11.42 12.62 10.06 17.03 17.027
Debt/Equity 0.01 0.01 0.02 0.02 0.02 0.02 0.01 0.01 0.00 0.004
Net Debt/Equity -1.07 -1.10 -1.11 -1.13 -1.15 -1.17 -1.19 -1.23 -0.97 -0.972
Debt/Assets 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.004
Debt/EBITDA -0.22 -0.09 -0.06 -0.04 -0.04 -0.04 -0.04 -0.03 0.01 0.008
Net Debt/EBITDA 17.37 7.30 3.48 2.62 2.62 2.60 2.92 2.79 -1.81 -1.809
Interest Coverage -160846.72 -368270.07 -683175.18 -841773.72 — — — — — —
Equity Multiplier 1.21 1.25 1.27 1.29 1.23 1.26 1.26 1.30 1.06 1.063
Cash Ratio snapshot only 15.748
Cash to Debt snapshot only 230.921
FCF to Debt snapshot only 105.234
Defensive Interval snapshot only 2257.2 days
Efficiency & Turnover
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Inventory Turnover — — — — — — — — — —
Receivables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Payables Turnover 0.08 0.07 0.59 0.51 0.46 0.17 0.79 0.30 0.46 0.463
DSO — — — — — — — — — —
DIO 0 0 0 0 0 0 0 0 0 0.0 days
DPO 4643 5511 622 721 789 2146 465 1218 788 787.9 days
Cash Conversion Cycle — — — — — — — — — —
Fixed Asset Turnover snapshot only 0.000
Cash Velocity snapshot only 0.000
Growth (YoY)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Current
Revenue — — — — — — — — — —
Net Income — — — — -4.2% -1.2% 6.0% 22.3% 3.8% 3.85%
EPS — — — — -4.2% -1.2% 5.3% 21.4% 3.8% 3.85%
FCF — — — — -2.2% -1.4% -0.5% 16.5% 3.6% 3.56%
EBITDA — — — — -4.2% -1.2% 2.6% 23.7% 3.7% 3.75%
Op. Income — — — — -4.7% -1.4% -12.2% 9.6% 20.3% 20.26%
OCF Growth snapshot only 3.61%
Asset Growth snapshot only 93.14%
Equity Growth snapshot only 1.24%
Debt Growth snapshot only -43.37%
Shares Change snapshot only -0.00%
Growth Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Current
Revenue Stability — — — — — — — — 1.00 1.000
Earnings Stability — — — — — — — — 0.56 0.561
Margin Stability — — — — — — — — — —
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — — 0.20 0.200
Earnings Smoothness — — — — — — — — — —
ROE Trend — — — — — — — — 0.78 0.782
Gross Margin Trend — — — — — — — — — —
FCF Margin Trend — — — — — — — — — —
Sustainable Growth Rate — — — — — — — — 74.7% 74.67%
Internal Growth Rate — — — — — — — — 2.0% 2.03%
Cash Flow Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Current
OCF/Net Income 1.43 0.89 0.91 0.87 0.90 0.97 0.97 0.95 0.82 0.825
FCF/OCF 1.03 1.03 1.02 1.02 1.02 1.01 1.01 1.01 1.00 0.999
FCF/Net Income snapshot only 0.823
OCF/EBITDA snapshot only 0.829
CapEx/Revenue — — — — — — — — — —
CapEx/Depreciation snapshot only 0.296
Accruals Ratio 0.02 -0.01 -0.02 -0.04 -0.03 -0.01 -0.01 -0.01 0.12 0.117
Sloan Accruals snapshot only 0.612
Cash Flow Adequacy snapshot only 691.100
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — 0.0% 0.00%
FCF Payout Ratio — — — — — — — — 0.0% 0.00%
Total Payout Ratio — — — — — — — — 0.0% 0.00%
Div. Increase Streak — — — — — — — — — —
Chowder Number — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -95.0% -157.8% -270.9% -291.4% -2.0% -1.7% -0.0% -1.1% -75.8% -75.83%
Total Shareholder Return -95.0% -157.8% -270.9% -291.4% -2.0% -1.7% -0.0% -1.1% -75.8% -75.83%
DuPont Factors
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Current
Tax Burden (NI/EBT) 0.95 0.98 0.99 0.99 1.00 1.00 1.01 1.01 1.00 0.999
Interest Burden (EBT/EBIT) 1.01 0.99 0.99 0.99 0.99 0.99 1.00 1.00 1.00 0.999
EBIT Margin — — — — — — — — — —
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Equity Multiplier 1.21 1.25 1.27 1.29 1.22 1.25 1.27 1.29 1.12 1.115
Per Share
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Current
EPS (Diluted TTM) $-0.20 $-0.46 $-0.85 $-1.04 $-1.02 $-0.99 $-0.80 $-0.82 $2.90 $2.90
Book Value/Share $3.30 $3.09 $2.71 $2.52 $2.40 $2.25 $2.07 $1.89 $5.38 $0.19
Tangible Book/Share $3.30 $3.09 $2.71 $2.52 $2.40 $2.25 $2.07 $1.89 $5.38 $5.38
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
FCF/Share $-0.29 $-0.42 $-0.78 $-0.93 $-0.93 $-0.98 $-0.79 $-0.78 $2.39 $0.05
OCF/Share $-0.28 $-0.40 $-0.77 $-0.91 $-0.92 $-0.97 $-0.78 $-0.78 $2.39 $0.05
Cash/Share $3.57 $3.44 $3.05 $2.88 $2.80 $2.67 $2.49 $2.35 $5.25 $0.09
EBITDA/Share $-0.20 $-0.47 $-0.86 $-1.08 $-1.05 $-1.02 $-0.84 $-0.83 $2.89 $2.89
Debt/Share $0.05 $0.04 $0.05 $0.04 $0.04 $0.04 $0.03 $0.03 $0.02 $0.02
Net Debt/Share $-3.53 $-3.40 $-3.00 $-2.83 $-2.76 $-2.64 $-2.46 $-2.33 $-5.22 $-5.22
Academic Models
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Current
Altman Z-Score — — — — — — — — — 2.480
Altman Z-Prime snapshot only 8.780
Piotroski F-Score 1 2 2 2 1 2 3 4 6 6
Beneish M-Score — — — — — — — — — —
Ohlson O-Score snapshot only -25.145
ROIC (Greenblatt) snapshot only 54.09%
Net-Net WC snapshot only $5.33
EVA snapshot only $-101270060.97
Credit
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Current
Credit Rating snapshot only A-
Credit Score 30.65 31.78 32.24 32.92 44.33 44.25 44.06 44.50 69.22 69.222
Credit Grade snapshot only 7
Credit Trend snapshot only 24.893
Implied Spread (bps) snapshot only 175.000
Industry Credit Rank snapshot only 76
Sector Credit Rank snapshot only 65

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms